{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:17:10Z","timestamp":1793881030923,"version":"4.7.0"},"reference-count":50,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les Hepatites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Hepatitis D virus (HDV) is a circular RNA virus coinfecting hepatocytes with hepatitis B virus. Chronic hepatitis D results in severe liver disease and an increased risk of liver cancer. Efficient therapeutic approaches against HDV are absent.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Here, we combined an RNAi loss-of-function and small molecule screen to uncover host-dependency factors for HDV infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Functional screening unravelled the hypoxia-inducible factor (HIF)-signalling and insulin-resistance pathways, RNA polymerase II, glycosaminoglycan biosynthesis and the pyrimidine metabolism as virus-hepatocyte dependency networks. Validation studies in primary human hepatocytes identified the carbamoyl-phosphatesynthetase 2, aspartate transcarbamylase and dihydroorotase (CAD) enzyme and estrogen receptor alpha (encoded by<jats:italic>ESR1<\/jats:italic>) as key host factors for HDV life cycle. Mechanistic studies revealed that the two host factors are required for viral replication. Inhibition studies using N-(phosphonoacetyl)-L-aspartic acid and fulvestrant, specific CAD and ESR1 inhibitors, respectively, uncovered their impact as antiviral targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The discovery of HDV host-dependency factors elucidates the pathogenesis of viral disease biology and opens therapeutic strategies for HDV cure.<\/jats:p><\/jats:sec>","DOI":"10.1136\/gutjnl-2018-317065","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T22:19:49Z","timestamp":1551737989000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets"],"prefix":"10.1136","volume":"69","author":[{"given":"Eloi R","family":"Verrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heydmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Turon-Lagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssein","family":"El Saghire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Crouchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5635-7437","authenticated-orcid":false,"given":"Patrick","family":"Pessaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam B","family":"Zeisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Sureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9022-5611","authenticated-orcid":false,"given":"Thomas F","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"2020050721383089000_69.1.158.1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1323623"},{"key":"2020050721383089000_69.1.158.2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.3.420"},{"key":"2020050721383089000_69.1.158.3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"The Lancet"},{"key":"2020050721383089000_69.1.158.4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/13543784.2017.1357695","article-title":"Investigational drugs in development for Hepatitis D","volume":"26","author":"Rizzetto","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"2020050721383089000_69.1.158.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.02.013"},{"key":"2020050721383089000_69.1.158.6","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/acs.biochem.7b00789","article-title":"Kinetic parameters of trans scission by extended hdv-like ribozymes and the prospect for the discovery of genomic trans-cleaving RNAs","volume":"57","author":"Webb","year":"2018","journal-title":"Biochemistry"},{"key":"2020050721383089000_69.1.158.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28013"},{"key":"2020050721383089000_69.1.158.8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12072-016-9718-5","article-title":"Hepatitis B virus receptors and molecular drug targets","volume":"10","author":"Verrier","year":"2016","journal-title":"Hepatol Int"},{"key":"2020050721383089000_69.1.158.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2015.07.009"},{"key":"2020050721383089000_69.1.158.10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acsinfecdis.5b00039","article-title":"Targeting viral entry for treatment of Hepatitis B and C virus infections","volume":"1","author":"Colpitts","year":"2015","journal-title":"ACS Infect Dis"},{"key":"2020050721383089000_69.1.158.11","doi-asserted-by":"crossref","unstructured":"Harak C , Meyrath M , Romero-Brey I , et al . Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture. Nat Microbiol 2016;2:16247.doi:10.1038\/nmicrobiol.2016.247","DOI":"10.1038\/nmicrobiol.2016.247"},{"key":"2020050721383089000_69.1.158.12","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3179"},{"key":"2020050721383089000_69.1.158.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00074-2"},{"key":"2020050721383089000_69.1.158.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.016"},{"key":"2020050721383089000_69.1.158.15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0907439106"},{"key":"2020050721383089000_69.1.158.16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1152725"},{"key":"2020050721383089000_69.1.158.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2013.10.001"},{"key":"2020050721383089000_69.1.158.18","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2012.711742"},{"key":"2020050721383089000_69.1.158.19","doi-asserted-by":"publisher","DOI":"10.1101\/gad.9.4.481"},{"key":"2020050721383089000_69.1.158.20","doi-asserted-by":"crossref","unstructured":"Kraus RJ , Yu X , Cordes BA , et al . Hypoxia-inducible factor-1\u03b1 plays roles in Epstein-Barr virus\u2019s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. PLoS Pathog 2017;13:e1006404.doi:10.1371\/journal.ppat.1006404","DOI":"10.1371\/journal.ppat.1006404"},{"key":"2020050721383089000_69.1.158.21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.retram.2016.11.002","article-title":"Hypoxia inducible factor one alpha and human viral pathogens","volume":"65","author":"Morinet","year":"2017","journal-title":"Curr Res Transl Med"},{"key":"2020050721383089000_69.1.158.22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat Commun"},{"key":"2020050721383089000_69.1.158.23","first-page":"1","article-title":"The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma","volume":"2014","author":"Luo","year":"2014","journal-title":"Biomed Res Int"},{"key":"2020050721383089000_69.1.158.24","doi-asserted-by":"crossref","first-page":"12171","DOI":"10.3748\/wjg.v21.i42.12171","article-title":"Hypoxia inducible factor in hepatocellular carcinoma: a therapeutic target","volume":"21","author":"Lin","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2020050721383089000_69.1.158.25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R400007200"},{"key":"2020050721383089000_69.1.158.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2005.07.003"},{"key":"2020050721383089000_69.1.158.27","doi-asserted-by":"publisher","DOI":"10.1261\/rna.065961.118"},{"key":"2020050721383089000_69.1.158.28","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1016\/S0021-9258(19)42149-2","article-title":"N-(phosphonacetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture","volume":"249","author":"Swyryd","year":"1974","journal-title":"J Biol Chem"},{"key":"2020050721383089000_69.1.158.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003678"},{"key":"2020050721383089000_69.1.158.30","first-page":"651","article-title":"Ribavirin: recent insights into antiviral mechanisms of action","volume":"4","author":"Reyes","year":"2001","journal-title":"Curr Opin Drug Discov Devel"},{"key":"2020050721383089000_69.1.158.31","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2011.21"},{"key":"2020050721383089000_69.1.158.32","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565150-00015"},{"key":"2020050721383089000_69.1.158.33","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.117"},{"key":"2020050721383089000_69.1.158.34","doi-asserted-by":"publisher","DOI":"10.1023\/B:BREA.0000003957.54851.11"},{"key":"2020050721383089000_69.1.158.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(99)01298-5"},{"key":"2020050721383089000_69.1.158.36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.20.6802"},{"key":"2020050721383089000_69.1.158.37","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2050"},{"key":"2020050721383089000_69.1.158.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2006.06.008"},{"key":"2020050721383089000_69.1.158.39","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/me.2016-1062","article-title":"The estrogen receptor \u03b1-cistrome beyond breast cancer","volume":"30","author":"Droog","year":"2016","journal-title":"Mol Endocrinol"},{"key":"2020050721383089000_69.1.158.40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4254\/wjh.v8.i2.123","article-title":"Ribavirin: past, present and future","volume":"8","author":"Loustaud-Ratti","year":"2016","journal-title":"World J Hepatol"},{"key":"2020050721383089000_69.1.158.41","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01795-13"},{"key":"2020050721383089000_69.1.158.42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.coviro.2016.06.003","article-title":"HBV cure: why, how, when?","volume":"18","author":"Levrero","year":"2016","journal-title":"Curr Opin Virol"},{"key":"2020050721383089000_69.1.158.43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0140-6736(17)30043-0","article-title":"Clinical development of hepatitis C virus host-targeting agents","volume":"389","author":"Zeisel","year":"2017","journal-title":"Lancet"},{"key":"2020050721383089000_69.1.158.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31715-9"},{"key":"2020050721383089000_69.1.158.45","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2018.01.107","article-title":"Leflunomide: a promising drug with good antitumor potential","volume":"496","author":"Zhang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2020050721383089000_69.1.158.46","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0212-x"},{"key":"2020050721383089000_69.1.158.47","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0664"},{"key":"2020050721383089000_69.1.158.48","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2341"},{"key":"2020050721383089000_69.1.158.49","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.30054","article-title":"Hepatitis B virus evasion from cyclic guanosine monophosphate-adenosine monophosphate synthase sensing in human Hepatocytes","volume":"68","author":"Verrier","year":"2018","journal-title":"Hepatology"},{"key":"2020050721383089000_69.1.158.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.09.084"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2018-317065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T04:33:07Z","timestamp":1694665987000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2018-317065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12,6]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/gutjnl-2018-317065"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2018-317065","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]}}}